Abiopharma

BNB Plus Corp. Announces Review of Strategic Alternatives to Maximize Shareholder Value

Accelsius Announces General Availability of NeuCool® IR150 and Launches NeuCool HyperStart Program at Data Center World 2026

Surf Air Mobility Improves Annual Adjusted EBITDA Guidance by Approximately 40% While Maintaining 20% to 30% Annual Revenue Growth Guidance

Tozorakimab met primary endpoint in Phase III MIRANDA trial in patients with COPD

Agi to Announce First Quarter 2026 Financial Results on May 5, 2026

OpenText Appoints James McGourlay as President, Chief Client Officer

Brady Corporation to Acquire Honeywell’s Productivity Solutions and Services Business, Expanding Portfolio with Data Capture and Workflow Solutions

Sable Confirms Extensive Outcropping Copper Mineralization within Multiple Structural Corridors at the Zorro Cu Target, Zorro Project, San Juan, Argentina

Pulse Biosciences’ nPulse™ Technology to be Featured at the Heart Rhythm Society 2026 Annual Meeting

Seres Therapeutics Showcases SER-155 Data and Live Biotherapeutic Insights at ESCMID Global 2026

Passage Bio Reports Updated Interim Data from upliFT-D Trial and Provides Regulatory and Corporate Updates

Canadian Solar Schedules First Quarter 2026 Earnings Conference Call for May 14

Perfect Announces Appointment of Financial Advisor and Legal Counsel to the Special Committee

Bicycle Therapeutics Provides Update on Nuzefatide Pevedotin and EphA2 Pipeline at the AACR Annual Meeting 2026

NRx Pharmaceuticals (Nasdaq:NRXP) Welcomes Presidential Initiative to Accelerate Approval of Psychedelic Medications to Treat Depression, PTSD, and Suicidality